According to Silicon Republic, Northern Ireland biosecurity startup Ilimex has raised €700,000 in seed funding to tackle airborne pathogens like Avian Flu. The company’s Flufence technology combines continuous pathogen detection with high-intensity UVC sterilization to neutralize viruses in agricultural settings. Founded in 2020 during the pandemic, Ilimex originally targeted public spaces but is now focusing on poultry and medicinal mushroom production. The funding came from Innovation Ulster Limited, Invest NI via Clarendon Fund Managers, and existing shareholders. Avian Flu has killed over 100 million birds in Europe and the US, causing $4-8 billion in agricultural losses according to the company.
Sponsored content — provided for informational and promotional purposes.
From classrooms to chicken coops
Here’s the thing about pandemic-era tech companies – many are having to pivot as COVID concerns fade. Ilimex started with schools and healthcare settings, but now they’re going where the money is. And in this case, that’s literally the chicken coop. The agri-food sector represents a massive opportunity, with CEO Gerry Corrigan estimating a £4 billion global market just for poultry air cleaning. That’s serious money for a problem that’s costing the industry billions in losses.
<h2 id="technology“>How Flufence actually works
The technology sounds pretty clever – it’s not just sterilizing the air, but detecting pathogens first. Basically, it’s a two-step process: find the bad stuff, then zap it with UVC light. This isn’t just about making the air cleaner – it’s about protecting entire production systems from contamination that can shut down operations. For poultry farmers dealing with Avian Flu outbreaks, this could mean the difference between staying in business or losing everything. And for mushroom growers? Apparently airborne contamination is a huge issue there too, with a £3.5 billion market opportunity across the UK, US and EU.
The real test begins now
The €700,000 isn’t for scaling up production – it’s for validation. Ilimex needs to prove their system actually works in real-world agricultural settings. They’ll be rolling out Flufence with key customer partners to collect data on performance and impact on profitability. This is the make-or-break phase. If they can demonstrate measurable improvements in efficiency and disease prevention, they’ll have farmers lining up. But if the data doesn’t show clear benefits? Well, that’s always the risk with new agricultural tech.
Why this matters beyond agriculture
Look, what’s interesting here isn’t just the potential to save chickens. It’s the validation of air sterilization technology in general. If Ilimex can prove their system works in these challenging environments, that opens up possibilities everywhere from food processing plants to hospitals. The pandemic made us all think about airborne pathogens differently, and companies that can deliver proven solutions stand to benefit. The question is whether Ilimex’s approach is the right one – or if there are better ways to tackle these problems. Only time and data will tell.
